Blog

You are currently viewing Why Do Some Cognitive Decline Patients Improve?
Not every brain is struggling for the same reason.

Why Do Some Cognitive Decline Patients Improve?

Why Do Some Patients Improve While Others Continue to Decline?

Some patients with Mild Cognitive Impairment (MCI), Alzheimer’s disease, and cognitive decline improve because the factors affecting their brain are identified and addressed early enough, thoroughly enough, and consistently enough. However, not every patient improves in the same way because every brain is different.

At the Carroll Institute in Sarasota, Florida, we believe one factor often rises above all others: how consistently the patient follows the protocol.

The Carroll Cognitive Method™ is not passive care. It is not simply taking a medication and hoping for the best. Instead, it is an interactive, personalized process that requires investigation, participation, consistency, and follow-through.

Why This Question Matters

Families often ask why one patient improves while another continues to decline. That question matters because people want to understand what creates the best opportunity for success.

For decades, patients were taught to think of cognitive decline as a one-way process. They were told to monitor symptoms, consider medication, and expect progression. However, Precision Medicine has changed that conversation.

The EVANTHEA Precision Medicine Trial demonstrated that meaningful improvement may occur when multiple contributors to cognitive decline are identified and addressed. That does not mean every patient improves. It does mean improvement is possible.

Therefore, the better question is not simply, “Can patients improve?” The better question is:

What factors determine whether this particular patient improves?

Every Patient Starts From a Different Place

No two patients with cognitive decline are exactly alike.

One person may have Mild Cognitive Impairment related to insulin resistance and poor sleep. Another may have early Alzheimer’s disease complicated by inflammation, vascular dysfunction, hormone imbalance, and mold exposure. A third may have genetic vulnerabilities that make recovery more difficult.

Because the starting points differ, the outcomes also differ.

Common factors that influence outcomes include:

  • How early the patient begins care
  • How advanced the cognitive decline has become
  • How many root causes are present
  • How much inflammation exists
  • How well the patient sleeps
  • How severe insulin resistance may be
  • Whether toxins or mold exposure are involved
  • Whether vascular disease is present
  • Whether genetic vulnerabilities exist
  • How consistently the patient follows the protocol

Genetics Can Influence Difficulty, But They Do Not Eliminate Hope

Some patients have genetic vulnerabilities that make cognitive recovery more challenging. APOE4, TOMM40, detoxification genes, inflammatory genes, and metabolic genes may all influence risk and treatment response.

However, genetics should not create hopelessness. Genes may influence vulnerability, but they do not determine destiny.

At the Carroll Institute, we use clinically relevant genetic information when appropriate. As a certified IntellxxDNA clinic, we can evaluate genetic pathways that may influence inflammation, detoxification, oxidative stress, metabolism, and brain health.

That information helps us personalize the plan. More importantly, it helps us understand where a patient may need additional support.

Root Causes Must Be Addressed

Cognitive decline usually does not come from one single cause. In many patients, several contributors affect the brain at the same time.

These may include:

  • Chronic inflammation
  • Insulin resistance
  • Sleep apnea
  • Hormonal imbalances
  • Vascular dysfunction
  • Nutritional deficiencies
  • Mold exposure
  • Heavy metals
  • Environmental toxins
  • Chronic stress
  • Brain network dysfunction

Consequently, a single medication cannot reasonably address every possible combination of these factors. Cognitive decline behaves more like a systems breakdown than a drug deficiency.

This is why the Carroll Cognitive Method™ focuses on identifying the actual factors affecting the brain rather than simply labeling the condition.

Compliance May Be the Most Important Factor

Although genetics, severity, and timing matter, one factor often becomes the most important practical difference between patients who improve and patients who do not.

That factor is compliance.

The Carroll Cognitive Method™ is an interactive protocol. Patients cannot simply take a pill and expect cognitive decline to resolve. Instead, they must participate actively in the process.

Depending on the patient, the protocol may involve:

  • Nutrition changes
  • Sleep improvement
  • Exercise
  • Stress reduction
  • Supplement protocols
  • Hormone support when appropriate
  • Toxin reduction strategies
  • Blood sugar regulation
  • Functional Neurology exercises
  • Follow-up testing and monitoring

In other words, the patient becomes an active participant in recovery.

That is one reason the Carroll Cognitive Method™ is different from conventional care. It does not treat the patient as a passive recipient. Instead, it gives the patient a structured plan and asks them to engage with it consistently.

Why Lifestyle-Based Root Causes Matter

Many root causes of cognitive decline are lifestyle-related. That does not mean the patient caused the problem. It means the patient may have power to influence the outcome.

Sleep, food, blood sugar, movement, stress, toxic exposure, and brain stimulation all affect cognitive health. Therefore, lifestyle is not a side issue. It is often central to recovery.

This is especially important because neuroplasticity requires the right environment. The brain adapts best when inflammation falls, energy improves, sleep strengthens, and neural pathways receive targeted stimulation.

At the Carroll Institute, we often describe neuroplasticity as a turbocharger for Precision Medicine. However, even the best plan cannot help if it is not followed.

Why Some Patients Decline Despite Care

Some patients continue to decline despite treatment. That can happen for several reasons.

The disease may be too advanced. Vascular damage may be severe. Trauma may have caused irreversible injury. Genetic vulnerabilities may create a heavier burden. In addition, some patients may struggle to follow the protocol consistently.

Sometimes, the root causes remain active. For example, a patient may improve nutrition but continue sleeping poorly. Another may begin supplements but remain in a mold-damaged environment. Someone else may complete testing but avoid exercise or brain-based rehabilitation.

Progress requires alignment between the plan and the patient’s daily choices.

What the EVANTHEA Precision Medicine Trial Supports

The EVANTHEA Precision Medicine Trial supports a systems-based approach to cognitive decline. Rather than focusing on one drug or one target, the trial addressed multiple contributors at the same time.

Those contributors included inflammation, metabolism, sleep, nutrition, exercise, hormones, stress, and cognitive stimulation. Participants demonstrated improvement in cognitive measures during the study period.

That result reinforces an important point: cognitive decline may improve when the right factors are identified and addressed. However, the model requires action. Patients must implement the plan.

The Carroll Cognitive Method™ Perspective

The Carroll Cognitive Method™ combines Precision Medicine, Functional Medicine, and Functional Neurology.

Precision Medicine helps identify the contributors affecting brain health. Functional Medicine helps address root causes. Functional Neurology helps evaluate and rehabilitate affected brain networks.

Together, these disciplines create a comprehensive and interactive protocol. The patient does not simply receive care. The patient participates in care.

That distinction matters.

The goal is not merely to slow decline. The goal is to improve function whenever improvement is possible.

Hope Without False Promises

Why do some patients improve while others continue to decline?

Because every patient begins with different biology, different root causes, different genetics, different disease severity, and different levels of participation.

No responsible clinician can promise the same result for everyone. However, patients who identify their contributors early and follow the protocol consistently often create the best opportunity for improvement.

That is not blame. It is empowerment.

When patients understand that their daily choices matter, they gain something many were never given before: a meaningful role in their own recovery.

Next Steps

If you or someone you love has Mild Cognitive Impairment, Alzheimer’s disease, memory loss, or cognitive decline, the most important question is not simply, “What diagnosis do I have?”

The better question is:

What factors are preventing this brain from improving?

If you are ready to explore a more active, personalized approach, we encourage you to schedule a discovery phone call with the Carroll Institute. Together, we can determine whether the Carroll Cognitive Method™ may be appropriate for your situation.

Sources

Medical Disclaimer

This information is provided for educational purposes only and is not intended as medical advice. Individual outcomes vary. No specific result can be guaranteed. Patients should consult a qualified healthcare professional regarding their individual medical situation.

Reviewed by: Dr. Garland Glenn, DC, PhD, IFM, AFMC

Location: Sarasota, Florida

Last Updated: June 20, 2026

Dr. Garland Glenn, DC, PhD, IFM, AFMC

Founder & Clinical Director, The Carroll Institute — Sarasota, FL

Dr. Garland Glenn is a board-certified chiropractic physician and functional medicine practitioner specializing in cognitive health, neurodegeneration, and root-cause medicine. Certified as an AFMC (Advanced Functional Medicine Clinician) and Institute for Functional Medicine (IFM) trained. He has also completed over 500 hours of advanced training in Functional Neurology under Dr. Ted Carrick, founder of the Carrick Institute.

At The Carroll Institute, Dr. Glenn leads Sarasota’s only ReCODE-certified Functional Neurology program, helping patients reverse or prevent cognitive decline through the Bredesen ReCODE Protocol, neuroplasticity exercises, and personalized functional medicine care.

Learn more about his background and approach at About Dr. Garland Glenn.

– schedule now –

free discovery call

To help you get started, we offer a free 20-minute Discovery Phone Consultation. During this call, you will be able to talk with one of our Certified Brain Health Coaches about what going on with you or your loved one and find out if we can help. Please review our FAQs prior to scheduling your free call. We look forward to talking with you soon and helping you Save Your Brain.

Let's get started

(yes, it’s totally free!)

ReCODE® is a registered program developed by Dr. Dale Bredesen and licensed through Apollo Health. Dr. Garland Glenn is a certified ReCODE practitioner.

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , ,